ConvaTec Director Declaration
Reading, United Kingdom (28 June 2021)
ConvaTec Group Plc ("ConvaTec" or "the Company") announces that Dr Regina Benjamin, Non-Executive Director of the Company, currently serves as a Director of Doximity, Inc. (NYSE: DOCS), which commenced trading on the New York Stock Exchange with effect from 24th June 2021.
This announcement is made in accordance with Listing Rule 9.6.14R.
Enquiries
Analysts and Investors
Kate Postans, VP Investor Relations +44 (0)7826 447807
Media
Buchanan: Charles Ryland / Chris Lane/ Hannah Ratcliff +44 (0)207 466 5000
ConvaTec Group Plc's LEI code is 213800LS272L4FIDOH92
About ConvaTec
ConvaTec is a global medical products and technologies company focused on therapies for the management of chronic conditions, with leading market positions in advanced wound care, ostomy care, continence and critical care, and infusion care. Our vision, which encompasses our purpose, is: Pioneering trusted medical solutions to improve the lives we touch. Our products provide a range of clinical and economic benefits including infection prevention, protection of at-risk skin, improved patient outcomes and reduced total cost of care. To learn more about ConvaTec, please visit www.convatecgroup.com.
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
